Hope, despair and CRISPR — the race to save one woman’s life Researchers in India fought to develop what could have been the first therapy to use gene-editing to halt a rare neurodegenerative disease. The efforts hold lessons for the messy state of modern drug development. By Heidi Ledford

https://www.nature.com/articles/d41586-024-01716-y?utm_source=Live+Audience&utm_campaign=8694cb95d3-nature-briefing-daily-20240612&utm_medium=email&utm_term=0_b27a691814-8694cb95d3-50432164https://www.nature.com/articles/d41586-024-01716-y?utm_source=Live+Audience&utm_campaign=8694cb95d3-nature-briefing-daily-20240612&utm_medium=email&utm_term=0_b27a691814-8694cb95d3-50432164